Followers | 70 |
Posts | 5279 |
Boards Moderated | 0 |
Alias Born | 02/11/2014 |
Re: Until2020, formerly Until2017 post# 6262
Friday, 06/13/2014 10:18:40 AM
Friday, June 13, 2014 10:18:40 AM
HERE IS THE FULL TEXT OF THE EMAIL : (Tuesday, December 10, 2013)
<<< Begin letter text >>>
Mr. ********,
Let me begin by explaining to you, and all other shareholders that I have no obligation to respond to your inquiry, however, since Tirex has not been forthcoming with it's shareholders, I am replying as a courtesy.
Tirex has NO, I repeat NO legal standing to "declare" that the agreement is "null and void". They executed a licensing agreement with GRSI, LLC and failed (as usual) to comply. We will be litigating, and we have an iron clad agreement to develop the technology.
Tirex does not,and has never, shown any concern for its shareholders/investors, who have not made one dime after all of these years.
GRSI, LLC has invested countless hours and significant monies in this project to date. Unfortunately, Tirex has breached all of the
contractual agreements between GRSI and Tirex.
We have sincerely made an effort to avoid litigation, but we can assure all of the shareholders that Tirex has forced our hand. Please refer to our website, which includes a copy of the U.C.C. filing, whereby, Tirex's patent was used as collateral.
We will proceed, post haste, with legal action to foreclose on the
patent.
Should you have any additional concerns, please direct your inquiries to Mr. John Threshie, the C.E.O. of the Tirex Corporation.
Sincerely,
Barbara Acuff
Chief Financial Officer
GRSI, LLC
<<< end of Letter >>>
Until2017
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM